Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
BioNTech faces hundreds of German compensation claims for Covid-19 jab
Ist Teil von
FT.com, 2023-06-11
Ort / Verlag
London: The Financial Times Limited
Erscheinungsjahr
2023
Link zum Volltext
Beschreibungen/Notizen
The challenge, in a regional court in Hamburg, is one of several hundred claims for compensation of up to €1mn being pursued by the two law firms. Ulbrich is a controversial figure, who has claimed that the American billionaire Bill Gates wanted to use vaccination to reduce the population of Germany to 27mn people — a claim that a spokesman for his foundation said was “false”. “Continuous monitoring of the vaccine’s safety profile and after more than 2.6bn doses of [the Covid-19 vaccine] administered worldwide has to date not identified potential side effects other than those already listed in the respective product information,” BioNTech said.